Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Notice: Multiple additions to the Prescription Drug List (PDL) [2025-02-26] February 26, 2025 Our file number: 25-101236-477 The purpose of this Notice of Amendment is to notify about (1) the addition of fezolinetant, iptacopan, and zolbetuximab to the Prescription Drug List…
Guide to the precision regulating authorities under the Food and Drugs Act: Overview Overview Supplementary rules authority Exemption authority Decision of foreign regulatory authority Definitions and interpretations On this page Objective Role of the regulator Background…
Animal-sourced insulin discontinuation: Notice Date published: March 18, 2025 Date updated: March 13, 2026 On this page Background What we've done What you can do Background There are 2 types of insulin used to manage diabetes: animal-sourced insulin human insulin and insulin…
Health Canada drafts guidance on co-packaged drug products: Notice On this page Background About the draft guidance How you can get involved Contact us Background Health Canada is consulting with stakeholders on a new draft guidance on co-packaged drug products, to reflect the…
Qualifying notice for Enhertu (285834) Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: e231047 Control number: 285834 [employee name removed] Project Manager, Regulatory Affairs…
Guide to the environmental risk management authorities under the Food and Drugs Act: Overview Overview Authority to require and disclose information Authority to order a label change or package modification Authority to recall the product Authority to compile information or…
Notice of intent: Removing carisoprodol from the Prescription Drug List March 26, 2025 Our file number: 25-102221-119 The purpose of this Notice of Intent is to announce that Health Canada will remove carisoprodol from the human and veterinary parts of the Prescription Drug List…
Nitrosamine impurities in medications: Recalls Overview Recalls Test methods and test results Guidance Established acceptable intake limits Report a problem or concern On this page What you should do Acyclovir recalls Amitriptyline recalls (updated) Angiotensin receptor blockers…
Notice of amendment: Correction to the Hetastarch entry on the Prescription Drug List Date: April 1, 2025 Our file number: 25-102331-499 The purpose of this Notice of Amendment is to announce that Health Canada has revised the listing of "Hetastarch or its derivatives" on the…
Notice of amendment: Carisoprodol removed from the Prescription Drug List April 14, 2025 Our file number: 25-102589-951 The purpose of this Notice of Amendment is to announce that Health Canada has removed carisoprodol from the Prescription Drug List (PDL) since its addition to…
Early release: coverage and features are still expanding.
